U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N3O3S
Molecular Weight 409.501
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CERLAPIRDINE

SMILES

CN(C)CCCOC1=CC2=C(NN=C2S(=O)(=O)C3=CC=CC4=C3C=CC=C4)C=C1

InChI

InChIKey=NXQGEDVQXVTCDA-UHFFFAOYSA-N
InChI=1S/C22H23N3O3S/c1-25(2)13-6-14-28-17-11-12-20-19(15-17)22(24-23-20)29(26,27)21-10-5-8-16-7-3-4-9-18(16)21/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,23,24)

HIDE SMILES / InChI

Molecular Formula C22H23N3O3S
Molecular Weight 409.501
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

PubMed

PubMed

TitleDatePubMed
Synthesis and structure-activity relationship (SAR) of (5,7-disubstituted 3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidin-2-yl)-methylamines as potent serotonin 5-HT(6) receptor (5-HT(6)R) antagonists.
2011 Dec 8
5-HT(6) receptor and cognition.
2011 Feb
Patents

Sample Use Guides

5-mg/day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:16:47 GMT 2023
Edited
by admin
on Fri Dec 15 17:16:47 GMT 2023
Record UNII
EK40PJ0V49
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CERLAPIRDINE
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
WAY-262,531
Code English
SAM-531
Code English
SAM-531 FREE BASE
Code English
Cerlapirdine [WHO-DD]
Common Name English
CERLAPIRDINE [USAN]
Common Name English
WAY-262531
Code English
PF-05212365
Code English
N,N-DIMETHYL-3-((3-(1-NAPHTHYLSULFONYL)-1H-INDAZOL-5-YL)OXY)PROPAN-1-AMINE
Systematic Name English
N,N-DIMETHYL-3-((3-((NAPHTHALEN-1-YL)SULFONYL)-1H-INDAZOL-5-YL)OXY)PROPAN-1-AMINE
Systematic Name English
cerlapirdine [INN]
Common Name English
1-PROPANAMINE, N,N-DIMETHYL-3-((3-(1-NAPHTHALENYLSULFONYL)-1H-INDAZOL-5-YL)OXY)-
Systematic Name English
Code System Code Type Description
FDA UNII
EK40PJ0V49
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
SMS_ID
100000164091
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
WIKIPEDIA
Cerlapirdine
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
INN
9553
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
NCI_THESAURUS
C169839
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
CAS
925448-93-7
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
ChEMBL
CHEMBL2103880
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
USAN
XX-143
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID201137232
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
EVMPD
SUB178433
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
PUBCHEM
16071605
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
DRUG BANK
DB12229
Created by admin on Fri Dec 15 17:16:47 GMT 2023 , Edited by admin on Fri Dec 15 17:16:47 GMT 2023
PRIMARY
Related Record Type Details
EXCRETED UNCHANGED
AMOUNT EXCRETED
URINE
EXCRETED UNCHANGED
AMOUNT EXCRETED
FECAL
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
TARGET->ANTAGONIST
Related Record Type Details
METABOLITE -> PARENT
PLASMA
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
URINE
METABOLITE -> PARENT
FECAL
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC ORAL ADMINISTRATION

SINGLE DOSE

Biological Half-life PHARMACOKINETIC SINGLE DOSE

ORAL ADMINISTRATION